🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study will investigate changes in the structure and function of blood v...
Status
Unknown
Location
Toronto Western Hospital
Start Date
2009-07
Trial ID
NCT01196325
A Phase 2 Multi center, Randomized, Controlled, Double-Masked Clinical Tria...
Status
Completed
Location
Associated Retina Consultants
Start Date
2014-10-13
Trial ID
NCT02348918
Treatments Being Tested
One of the most frequent complications of diabetic retinopathy is diabetic ...
Status
Completed
Location
JiWon Lim
Start Date
2009-03
Trial ID
NCT01342159
Treatments Being Tested
Multicenter randomized trials have demonstrated the safety and efficacy of ...
Status
Unknown
Location
Maisonneuve Rosemont Hospital
Start Date
2016-11
Trial ID
NCT02924987
Treatments Being Tested
The study will compare the safety of ophthalmic bevacizumab in vials versus...
Status
Active Not Recruiting
Location
Clinical Site
Start Date
2021-11-15
Trial ID
NCT05112861
Treatments Being Tested
To compare the efficacy and safety results of intravitreal bevacizumab alon...
Status
Unknown
Location
Hamid Ahmadieh, MD
Start Date
2005-11
Trial ID
NCT00370370
Treatments Being Tested
This is a phase 4 prospective, nonrandomized, open label, interventional cl...
Status
Completed
Location
Southeast Retina Center
Start Date
2015-06
Trial ID
NCT03340610
Treatments Being Tested
The purpose of this study is to determine the effect of pre- and intra-oper...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2008-06
Trial ID
NCT00745498
Treatments Being Tested
This randomized controlled trial compares two techniques for eyelid retract...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06
Trial ID
NCT07481500
Treatments Being Tested
Bevacizumab is an anti-VEGF agent used in approved for use in metastatic co...
Status
Unknown
Location
Sivakami Pai
Start Date
2006-08
Trial ID
NCT00403026
Treatments Being Tested